Valiant Laboratories Ltd Nine Monthly Results

Gross Sales

75.6

151.47

242.64

Excise Duty

0

0

0

Net Sales

75.6

151.47

242.64

Other Operating Income

0

0

0

Other Income

7.75

7.18

2.13

Total Income

83.35

158.65

244.77

Total Expenditure

84.1

155.35

217.06

PBIDT

-0.76

3.3

27.7

Interest

0.12

0.06

0.23

PBDT

-0.88

3.24

27.48

Depreciation

1.57

1.45

1.12

Minority Interest Before NP

0

0

0

Tax

0.42

0.6

6.57

Deferred Tax

0.03

-0.36

0.37

Reported Profit After Tax

-2.91

1.56

19.42

Minority Interest After NP

0

0

0

Net Profit after Minority Interest

-2.91

1.56

19.42

Extra-ordinary Items

0

0

0

Adjusted Profit After Extra-ordinary item

-2.91

1.56

19.42

EPS (Unit Curr.)

-0.67

0.4

11.93

Book Value (Unit Curr.)

0

0

0

Dividend (%)

0

0

0

Equity

43.45

43.45

16.28

Public Shareholding (Number)

0

0

0

Public Shareholding (%)

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

Non Encumbered - No. of Shares

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

Non Encumbered - % in Total Equity

0

0

0

PBIDTM(%)

-1

2.17

11.41

PBDTM(%)

-1.16

2.13

11.32

PATM(%)

-3.84

1.02

8